Clinical trial
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting…
NCT00287573 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00287573 |
|---|---|
| Title | Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis |
| Official title | A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis |
| Acronym | TAXUS V ISR |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Restenosis |
| Intervention type | Device, Procedure |
| Interventions | TAXUS Express2, Brachytherapy (beta source) |
| Enrollment | 488 |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Jan 1, 2010 |
| First posted | Feb 7, 2006 |
| Last update posted | Aug 6, 2010 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: